Home
CLYM vs GNSS Comparison

CLYM vs GNSS Comparison

Compare CLYM & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CLYM

GNSS

Machine Learning Prediction

ML Decision
CLYM
GNSS

Stock Information

Founded
CLYM 2018
GNSS 1992

Country
CLYM United States
GNSS United States

Employees
CLYM N/A
GNSS N/A

Industry
CLYM
GNSS Consumer Electronics/Appliances

Sector
CLYM
GNSS Consumer Staples

Exchange
CLYM NYSE
GNSS Nasdaq

Market Cap
CLYM 101.6M
GNSS N/A

IPO Year
CLYM 2021
GNSS N/A

Fundamental

Price
CLYM $1.28
GNSS $2.27

Analyst Decision
CLYM
GNSS Strong Buy

Analyst Count
CLYM 0
GNSS 3

Target Price
CLYM N/A
GNSS $5.33

AVG Volume (30 Days)
CLYM 181.1K
GNSS 155.8K

Earning Date
CLYM 03-25-2025
GNSS 05-13-2025

Dividend Yield
CLYM N/A
GNSS N/A

EPS Growth
CLYM N/A
GNSS N/A

EPS
CLYM N/A
GNSS N/A

Revenue
CLYM N/A
GNSS $26,587,000.00

Revenue This Year
CLYM N/A
GNSS $121.93

Revenue Next Year
CLYM N/A
GNSS $68.26

P/E Ratio
CLYM N/A
GNSS N/A

Revenue Growth
CLYM N/A
GNSS N/A

52 Week Low
CLYM $1.20
GNSS $1.65

52 Week High
CLYM $11.55
GNSS $4.04

Technical

Relative Strength Index (RSI)
CLYM N/A
GNSS 38.70

Support Level
CLYM N/A
GNSS $2.30

Resistance Level
CLYM N/A
GNSS $2.45

Average True Range (ATR)
CLYM 0.00
GNSS 0.14

MACD
CLYM 0.00
GNSS 0.02

Stochastic Oscillator
CLYM 0.00
GNSS 50.00

About CLYM CLIMB BIO INC

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.

Share on Social Networks: